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Background: Women are usually not considered for abdominal aortic aneurysm (AAA) screening because of their lower
prevalence of disease. This position may, however, be questioned given the higher risk of rupture and the longer life
expectancy among women. The purpose of this study was to assess the cost-effectiveness of screening 65-year-old women
for AAA.
Methods: A systematic review of the literature was conducted to obtain data of importance to evaluate the effectiveness of
screening women for AAA. Data were entered into a Markov simulation cohort model.
Results: The review suggested some main assumptions for women with AAA. Prevalence is 1.1%. In 6.8%, the AAA is of
a size that merits surgery, and the patients are fit for a procedure. For patients with an AAA, the yearly risk for elective
surgery and the rupture incidence was 3.1% and 2.4%, respectively, in the invited group and 1.1% and 5.7% in the
noninvited group. The operative mortality for elective surgery was 3.5%, and the total mortality for ruptured AAA was
86.3%. The long-term mortality for AAA patients was 3.6 times higher than for an age-matched healthy population.
Screening reduced the AAA rupture incidence by 33% and the AAA-related death rate by 35%. The cost per life year gained
was estimated at $5911.
Conclusion: The incremental cost-effectiveness ratio was similar to that found for screening men, which reflects the fact
that the lower AAA prevalence in women is balanced by a higher rupture rate. Screening women for AAA may be
cost-effective, and future evaluations on screening for AAA should include women. (J Vasc Surg 2006;43:908-14.)Women are generally not considered a suitable target
population for abdominal aortic aneurysm (AAA) screen-
ing. The main reason is not only the low prevalence of
AAA1-3 but also a development of the disease later in life4
and an inferior relative long-term survival in women with
AAA.5,6 However, other aspects of the disease, such as the
higher rupture rate, indicate that AAA in women may be
more severe than in men.7,8 Even though women with AAA
have a higher mortality than disease-free women, the over-
all life-expectancy for women exceeds that of men.9 The
objective of this study was to assess the cost-effectiveness of
screening women for AAA. A previously developedMarkov
simulation model was used, and data for the study were
obtained by a systematic review of the literature.
METHODS
The Markov cohort simulation model was originally
developed to evaluate the cost-effectiveness of different
screening strategies for AAA in men. The model was de-
scribed in detail previously10 and is reviewed briefly. Two
hypothetical groups of 65-year-old womenwere compared.
One group was invited to ultrasound screening, but the
other was not invited. The model follows a cohort of
From the Departments of Surgery, Uppsala University Hospital,a and Med-
ical Management Centre, Karolinska Institute.b
Supported by grants from the Swedish Research Council K2002-73X-
14222-01A.
Competition of interest: none.
Reprint requests: Dr Anders Wanhainen, Department of Surgery, Upp-
sala University Hospital, SE-371 85 Uppsala, Sweden (e-mail: andwan@
algonet.se).
0741-5214/$32.00
Copyright © 2006 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2005.12.064
908patients from the time of screening until death or 100 years
of age. The lifetime is divided into 1-year cycles. Those not
attending are assumed to be similar to the noninvited group
regarding risk of the different events.
Patients with a detected AAA have yearly revisits to follow
the expansion of the aneurysm. They are offered elective open
surgery, if they are healthy enough, when the AAA has grown
to 55 mm, has expanded rapidly, or has caused symptoms.
Some patients with detectedAAA fulfill the criteria for elective
surgery at the time of screening and will be offered surgery as
soon as possible. A proportion of the AAA in the nonscreened
group will be detected opportunistically.
Each year, patients with AAA are at risk of rupture or
death, either related to the AAA or due to other causes.
False-negative AAAs or false-positive ultrasound measure-
ments at screening were not explicitly included in the
model. The model is graphically depicted in Fig 1.
In the previous publication, male-specific data were
obtained by a systematic review of the literature.10 These
probabilities were adjusted when important differences be-
tween men and women were found in the literature review.
In a Medline search through January 2005, the keyword
abdominal aortic aneurysm was combined with gender,
sex, women, and female. The following selection criteria
were used:
1. Only population-based or multicenter studies were ac-
cepted.
2. The paper should be an original clinical research report
published after 1990 and written in English or Scandi-
navian languages.
3. The definition of an AAA should be given, 30 mm
being used in the present study.
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5. Only open repair was assessed in the model, and a
distinction between surgery for ruptured and nonrup-
tured AAA should be possible.
Thirty-two studies with female-specific data were iden-
tified and read in full by the main investigator (A.W.). Of
these reports, 18 contained suitable data to be extracted
and used as basis for the parameter estimates in the model.
The cost per life year gained was the outcome measure.
Costs and effects were discounted at 3% annually. All costs are
presented in USD 2004 values, updated using the Swedish
consumer price index.9 One- and two-way sensitivity analyses
were performed to assess how selected parameters affected the
results.
RESULTS
Model probabilities. Table I presents the probabili-
ties in the model and the related data for men. The age-
adjusted male/female prevalence ratio was 5:1, based on
four screening studies on both sexes.2,3,11,12 With an as-
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Fig 1. Model structure. Each circle represents a Markov state.
The shaded circle labeled DEAD represents an absorbing state,
from where a person cannot leave. Arrows indicate allowed transi-
tions. The transition probabilities differ between the two groups;
invited to ultrasound screening or not invited. Those not attending
are assumed to be similar to the noninvited group regarding
transition probabilities.sumed prevalence of 5.5% among 65-year-old men,10 theprobability of a positive screening result for women was
estimated at 1.1%. Of these, 6.8% were assumed to be
qualified and fit for immediate surgery.10
It was assumed that 72% of those invited would attend
screening3,13 and, based on the difference in rate of elective
surgery between the screened and nonscreened groups in
four prospective studies,14-17 that 13% of the AAAs in the
nonscreened patients would be opportunistically detected.
The rate of elective AAA surgery was lower for women
than men with AAA.18-20 It was estimated at 3.1% per year
among women with AAA attending screening and at 1.1%
among women with AAA not attending screening or not
invited to screening compared with 3.9% and 1.4% in men
with AAA.10 Patients undergoing surgery for nonruptured
AAA were assumed to have a perioperative mortality of
3.5%, based on the mortality of the Swedvasc database (the
Swedish National Vascular Registry) for women operated
on during 2000 through 2004.21 Mortality data from the
Swedvasc is 100% correct, given the unique personal iden-
tity code of each Swedish citizen and that the registry is
cross-matched against the population registry once a
month. The operative mortality was assumed to be the
same in the invited and noninvited groups.
Among men, the rupture risk of an AAA was estimated
at 0.8% per year among those with an AAA attending a
screening and 1.9% among those with an AAA not attend-
ing a screening or not invited to a screening.10 Women
were estimated to have a threefold higher rupture risk than
men.8 Thus, the corresponding annual rupture risks were
2.4% and 5.7%, respectively, for women with AAA.
Sixty-five percent of men with ruptured AAA die before
surgery, and an additional 14% die during surgery, corre-
sponding to an operative mortality of 40%.10 The rate of
surgery for ruptured AAA was lower for women,19,20,22
and the operative mortality was higher.5,18,23 Thus, the
total mortality for AAA rupture was estimated at 86.3% for
women compared with 79% for men. Because of comorbid-
ity, patients with AAA were assumed to have an increased
relative mortality, unrelated to the AAA, compared with
the general age- and sex-matched population. The in-
creased relative mortality was higher for women with AAA
than men with AAA5,6 and was estimated to be 3.6 times
the normal mortalities both before and after surgery for
AAA. The estimate corresponds to a relative age- and sex-
matched survival of 82.5% after 5 years for women com-
pared with 90% for men.10 Normal age- and sex-specific
death rates were based on population mortality statistics for
Swedish women.9
Costs. The cost for inviting persons to the screening is
incurred by all invited patients, whereas the cost of the
screening procedures only is incurred by those who attend.
The cost of invitation was estimated at $5.60 and the cost
of screening at $54.80.24 The estimated cost for traveling
to the screening was $5.60, based on an assumed cost for
traveling within a Swedish city.
Patients with a detected AAAwere assumed to come for
yearly revisits to control the expansion of the aneurysmwith
ultrasound scans. The estimated cost of these revisits was
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added at the time of detection for informing the patients
about the AAA.25 The estimated cost of elective AAA
surgery was $16,898, and the estimated cost of surgery for
a ruptured AAA was $32,310.26 The consequences of
including costs in added years of life were tested in sensi-
tivity analysis.27
Model results. The estimated mean remaining life e x -
pectancies in the invited and noninvited groups were 19.83
and 19.81 years, respectively, and the base-case estimated
cost per life year gained was $5911. The rupture incidence
was 0.29% in the invited group and 0.43% in the noninvited
group. The AAA-related death incidence was 0.26% for the
invited group and 0.41% for the noninvited group, which
corresponds to a 35% reduction. The base-case results are
presented in Table II.
One-way sensitivity analyses are displayed in Figs 2, 3,
and 4. A prevalence of 0.6% resulted in a cost per life year
gained of $9253 (Fig 2). A relative rupture risk of 0.8% in
the invited group and 1.9% in the noninvited group (same
as for men)10 resulted in a cost per life year gained of
$17,099 (Fig 3). The cost per life saved year was $3422,
with an assumed relative long-term mortality of 2.05 for
patients with AAA (same as for men)10 (Fig 4). Additional
one- and two-way sensitivity analyses (Table III) indicate
that the results were robust for variations in other model
Table I. Summary of model probabilities for women and
for men as comparison
Assumption
Probability
Women Men
Prevalence 1.10% 5.50%
Proportion of AAA qualified and
fit for immediate surgery 6.80% 6.80%
Attendance rate 72% 80%
Proportion of opportunistically
detected AAA 13% 13%
AAAs yearly risk for non-ruptured
AAA surgery, screened group 3.12% 3.90%
AAAs yearly risk for non-ruptured
AAA surgery, non-screened
group 1.12% 1.40%
Mortality for non-rupture AAA
surgery 3.50% 3.10%
Total mortality for ruptured AAA 86.30% 79%
Yearly risk of rupture among those
with AAA, screened group 2.40% 0.80%
Yearly risk of rupture among those
with AAA, non-screened group 5.70% 1.90%
AAA patient relative long term
mortality 3.59 2.05
Cost of screening, including
invitation and traveling $66.10 $66.10
Cost of follow-up $243.40 $243.40
Cost of elective AAA surgery $16,898 $16,898
Cost of surgery for ruptured AAA $32,310 $32,310
Discounting (annually) 3% 3%
AAA, Abdominal aortic aneurysm.parameters.DISCUSSION
The Chichester screening trial is the only published
evaluation of screening for AAA in women. Some 9342
women aged 65 to 80 years (mean age, 72 years) were
randomized, with no difference in rupture rate between the
screened and the control groups after 10 years follow-up.
The authors concluded that it was neither clinically
indicated nor economically rational to screen women.28
However, a possible limitation that is likely to counteract
the possible benefits of screening women is the biased
mortality data based on official statistics. With a low au-
topsy rate, the reliability is limited in determining mortality
rate from ruptured AAA. The autopsy rate has decreased to
an overall 11% in Sweden, and is almost nonexistent among
women 80 years old.29
Our analyses showed that the cost-effectiveness was rather
insensitive t o variations in prevalence 1%. Below this level,
however, the cost per life year gained increased rapidly
(Fig 2). The prevalence of the disease is, however, highly
dependent on the definition used.12 In most population-
based screening studies including women,2,3,11,12 an AAA
was defined as the maximum infrarenal aortic diameter
being 30 mm, as proposed by McGregor.30 Because the
normal aortic diameter differs by gender,31 a fixed diameter
may not be an optimal definition of AAA and may partly
explain the differences seen in prevalence between men and
women.
In the Chichester trial, four of the 10 women from the
screened group who had AAA rupture or emergency repair
initially had a normal scan.28 This may be the result of how
an AAA was defined, where a fixed diameter may result in
false-negative findings, or a consequence of the natural
history of AAA development among women. Our study
design did not including these possible effects. The preva-
lence also depends on the age of the screened population.
However, the present lack of age-specific prevalence data in
womenmakes a more precise analysis of the optimal screen-
ing age difficult.
In addition to the prevalence of the disease, the most
striking epidemiologic difference betweenmen and women
Table II. Base case results (screening 65-year-old women
once), per person
Noninvited
Invited for
screening Difference
Cost*
Invitation cost 0 5.60 5.60
Screening cost 0 39.50 39.50
Follow-up cost 2 13.70 11.70
Elective surgery cost 12.40 35.00 22.60
Rupture surgery cost 40.50 24.20 16.30
Total cost 54.90 117.90 63.00
Effectiveness (life years) 14.402 14.412 0.011
Incremental cost-
effectiveness ratio 5 911
*Cost in United States dollars.is a higher rupture rate among women. Gender differences
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and an observed increased growth rate of AAA in women35
indicate gender differences in the natural course of the
disease. In an observational study of AAA patients unfit for
surgery, the annual rupture rate was 1% in men compared
with 4% in women with AAA of 50 to 59 mm and 14.1%
compared with 22.3% with AAA 60 mm.7 Among 2257
AAA patients enrolled in the UK Small Aneurysm Trial
(UKSAT) or Small Aneurysm Study, the risk of rupture
was, independently of age and initial AAA diameter, asso-
ciated with female sex. The rupture rate was three times
higher in women compared with men.8
The rupture rate has a large impact on the cost-
effectiveness of a screening program,10 and the higher
rupture rate among women compensates for the lower
prevalence and reduces the cost per life year saved by 64%
(Fig 3). Basing the assumed rupture rate among women on
the results of only one study is surrounded by uncertainties.
The sensitivity analysis showed, however, that the incre-
mental cost per life year gained was lower than what is
generally considered cost-effective, even if the rupture rate
among women with AAA was assumed to be the same as for
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Fig 2. Cost-effectiveness at different prevalences of abdominal
aortic aneurysm. USD, United States dollars.
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Fig 3. Cost-effectiveness at different relative rupture risk com-
pared with those for men (relative rupture rate, 1.0).USD,United
States dollars.men (Table III, Fig 3).The observed differences in surgery rates between
women and men18-20,22 were not explained by differences
in AAA prevalence, hospitalization rate, age, or contraindi-
cations for surgery.20 A possible reduced awareness of AAA
in women,22 or gender bias in the decision to operate20 or
when to operate may therefore exist, although the effect on
the cost-effectiveness was only marginal in the present
study. In men, an AAA diameter of 55 mm generally
justifies elective repair,36,37 whereas it has been suggested
that women may benefit from a lower threshold for sur-
gery.7,8 A lower threshold diameter for surgical repair in
women (50 mm) may reduce the difference in surgery
rate and the likelihood of an AAA to rupture. In the
UKSAT, the mean AAA diameter at rupture was 50 mm for
women and 60 mm for men. They concluded that different
thresholds should apply to women than men when AAA
repair is being considered.8 In the Chichester trial, how-
ever, a threshold diameter of 60 mm did not result in higher
rupture rate.28
The reports on mortality differences between men
and women for nonrupture AAA surgery are inconsistent.
In several large population-based studies, no gender
difference in mortality was found.6,34,38,39 Using multiple
logistic regression analysis, Heller et al39 found no gender
difference in mortality after elective AAA surgery in
360,000 patients over a 19-year period in the United
States, but a significant difference in postoperative mortal-
ity after ruptured AAA was found (68,000). Others have
found female gender to be a risk factor for death after
surgery for nonruptured AAA, with an OR of 1.3 to
1.6.18,40-42 Among 555 women operated on with intact
AAA (elective or emergent nonruptured AAA) and re-
ported to the Swedish Vascular Registry in 2000 through
2004, the 30-day mortality was 3.9%.21 Excluding endo-
vascular aneurysm repair (18% of the operations), the mor-
tality decreased to 3.5%. The corresponding mortality for
men was 3.1%. Mortality after surgery for nonruptured
AAA is lower in Sweden compared with some previous
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Fig 4. Cost-effectiveness at different relative mortality risk for
abdominal aortic aneurysm patients compared with a general,
age-matched population (relative mortality risk, 1.0). USD,
United States dollars.reports but is well validated. Furthermore, an assumed 50%
9 (85
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effectiveness (Table III).
We previously showed that the life expectancy of the
screened individuals is a key variable for the cost-effectiveness
ratio.10 Because of comorbidity, men with AAA have an
increasedmortality, unrelated to the AAA, compared with a
general aged-matched population.10 The relative long-
term survival after surgery for AAA was found to be better
in men than in women,5 although the crude long-term
survival was similar between men and women, because
women in general have a longer life expectancy.6 The
assumed additional relative mortality in women with AAA
compared with men increased the cost per life years saved
by 30% in our model (Fig 3).
Women seem to attend screening slightly less than
men.3,13 The attendance rate, however, has very little im-
pact on the cost-effectiveness ratio.10 This may, however,
not be the case if the nonattenders are different from those
attending screening. As stated previously, the life expect-
ancy of the screened person is a key variable for the cost-
effectiveness ratio. A paradoxical effect could thus occur: if
people who attend screening are healthier than those who
do not attend, the cost-effectiveness could increase with a
decrease of the attendance rate.
We were rather surprised by the finding that the de-
crease in AAA-specific mortality among women invited to
screening was only 32% compared with 50% among men.
The explanation lies in the complex relations between
mortality, risk of rupture, and risk of elective surgery. If
Table III. Results from sensitivity analyses
Parameter Assumption
Base case (screening 65-year-old women once)
Elective surgery mortality 5.30%
Ruptured AAA total mortality 79%
Attendance rate 50%
Yearly risk of rupture† 1.6%/3.8%
Yearly risk of rupture† 0.8%/1.9%
Elective surgery costs 50%
50%
Ruptured surgery costs 50%
50%
Cost of screening 100%
50%
Including cost in added years of life‡
Discount rate 0%
6%
Cost of screening 100% and elective surgery
mortality 5.3%
Cost of screening 100% and yearly risk of
rupture† 1.6%/3.8%
Cost of screening 100% and yearly risk of
rupture† 0.8%/ 1.9%
AAA, Abdominal aortic aneurysm.
*Compared to no invitation to screening.
†Among those with AAA, screened group/nonscreened group.
‡Using costs of $24,588 (65-74 years), $28,300 (75-84 years) and $40,19women had an identical compliance and rupture rate asmen, the model would generate a decrease in AAA-specific
mortality of 43%.
In a consensus statement by Kent et al,43 women aged
60 to 85 years with cardiovascular risk factors and women
50 years with a family history of AAA, who appear fit for
any intervention, were considered a suitable screening pop-
ulation.43 A recent systematic review for the United States
Preventive Service Task Force by Fleming et al44 found no
evidence in the literature of the benefit of screening women
regardless of risk factors. In a previous report on men, we
demonstrated a trade-off between high prevalence of AAA
and lower life expectancy, eliminating the expected benefits
of screening high-risk groups such as smokers or cardiovas-
cular patients.10 Whether this is true also for women re-
mains to be shown.
The present study showed that the incremental cost per
life year gained for screening all 65-year-old women for
AAA was lower than what is generally considered cost-
effective27,45,46 and was similar to that for screening men at
the same age.10,24 This reflects the fact that in women, a
low prevalence is balanced by a high rupture rate.
CONCLUSION
Although the results should be interpreted with some
caution because women-specific epidemiologic data are
scarce, the findings in this study do not justify the exclusion
of women in future evaluations of the pros and cons of
screening for AAA. Screening women for AAA may be
cost-effective, and future prospective evaluations on screen-
Cost difference ($)*
Difference in
life years*
Cost per life year
gained ($)*
63.00 0.011 5911
63.00 0.010 6016
60.10 0.010 6183
45.50 0.007 6142
67.40 0.008 8551
73.30 0.004 17,099
74.30 0.011 6972
51.70 0.011 4850
54.90 0.011 5145
71.20 0.011 6677
102.50 0.011 9612
43.30 0.011 4061
347.80 0.011 32,626
65.70 0.014 4555
61.00 0.008 7573
102.5 0.010 9783
106.9 0.008 13,554
112.80 0.004 26,302
years).ing for AAA should include women.
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In the current issue of Journal of Vascular Surgery, Wanhainen
et al address the controversial but timely question of whether
women should be screened for abdominal aortic aneurysms
(AAAs). The publication of this manuscript coincides temporally
with a landmark accomplishment in the United States, as legisla-
tion mandating reimbursement for AAA screening for 65-year-
old ever-smoking men has now passed the Senate and House of
Representatives and, with luck, will soon be signed into law.
Although, there now appears to be relatively uniform consensus
that AAA screening is useful in men, for women, the controversy
continues on.
It has long been understood that AAAs are less prevalent in
women than in men, and there is little doubt that disease preva-
lence is a critical contributor to the cost-effectiveness of screening.
Moreover, the Chichester Aneurysm Study, a small but random-
ized study, did not demonstrate an advantage of AAA screening in
women. But as clearly established by the authors of this article,
prevalence is not the only factor of importance when evaluating the
cost-effectiveness of aneurysm screening.
When it comes to aneurysms, there is little dispute that women
behave differently than men. Yes, prevalence is less in women;
however, aneurysms in women rupture at an increased rate and at
a smaller size. Paraphrased, fewer aneurysms are found by screen-
ing women, but the ones that are found are more dangerous.
Although the ratio of prevalence is fairly well established at approx-rupture in women is less well documented. The authors, in their
base case analysis, use a ratio of 3:1, women vs men, based upon
data from the United Kingdom Small Aneurysm Study.
Wanhainen et al also point out that in addition to prevalence
and rupture rate, multiple other factors are essential to this analysis,
including patient longevity, which appears to be less in women
with AAA than in men, and death after rupture, which is greater in
women than in men. The outcome of all of these factors, when
introduced into a detailed Markov model, is that screening for
AAA in women is extremely cost-effective. Moreover, in sensitivity
analyses, the cost-effectiveness of screening remains robust despite
a number of variations in assumptions, including prevalence.
Cost-effective analyses are only as good as the data that are
introduced into the model, and as Wanhainen et al clearly state,
there are a paucity of data regarding the natural history of aneu-
rysms in women. However, until more data become available, it
seems prudent to be inclusive of women in screening programs. In
light of this analysis, the recent opinion rendered by the United
States Preventative Service Task Force, that “screening in women is
harmful,” seems unwarranted.
One fact that we can all agree on is that aneurysms behave
differently in women than in men. The responsibility is ours to
better understand these differences. Until more data becomes
available it seems best to be inclusive rather than exclusive and
include high risk women in our screening programs.
